| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +0.00% | +2.78% | +1.00% | +1.78% | +1.78% | — |
| 14d | 2 | +0.00% | +1.42% | +1.24% | -0.44% | -0.44% | — |
| 30d | 2 | +50.00% | -1.28% | +0.74% | -2.03% | -2.03% | — |
| 60d | 2(1 pending) | +100.00% | -1.54% | -0.42% | -1.12% | -1.12% | — |
| 90d | 2(1 pending) | +0.00% | +8.72% | -4.00% | +12.72% | +12.72% | — |
| 180d | 2(1 pending) | +0.00% | +12.53% | +9.31% | +3.22% | +3.22% | — |
| 1y | 2(2 pending) | — | — | — | — | — | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| JANX JANUX THERAPEUTICS, INC. | SALE Vice President, Accounting | 2,038 | $14.17 | $28.9K | 32,270 | May 11, 2026 | May 13, 2026 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | SALE Vice President, Accounting | 1,462 | $13.73 | $20.1K | 15,373 | Jan 2, 2026 | Jan 2, 2026 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 18,935 | — | — | 34,308 | Jan 2, 2026 | Jan 2, 2026 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 42,600 | — | — | 42,600 | Jan 2, 2026 | Jan 2, 2026 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 31,500 | — | — | 31,500 | Jan 2, 2025 | Jan 3, 2025 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 14,000 | — | — | 14,001 | Jan 2, 2025 | Jan 3, 2025 ↗ | View → |